AMPK Activation Stimulates Autophagy and Ameliorates Muscular Dystrophy in the mdx Mouse Diaphragm

Pauly, Marion, Daussin, Frederic, Burelle, Yan, Li, Tong, Godin, Richard, Fauconnier, Jeremy, Koechlin-Ramonatxo, Christelle, Hugon, Gerald +6 more·2012·The American Journal of Pathology
DOI 10.1016/j.ajpath.2012.04.004

Cited by (225)

Items 101–200 of 225

  1. Treatment with l-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial
    Patricia Hafner, Ulrike Bonati, Daniela Rubino, Vanya Gocheva, Thomas Zumbrunn, Nuri Gueven, Dirk Fischer · 2016 · Trials
  2. Metformin Reverses the Enhanced Myocardial SR/ER–Mitochondria Interaction and Impaired Complex I-Driven Respiration in Dystrophin-Deficient Mice
    Claire Angebault, Mathieu Panel, Mathilde Lacôte, Jennifer Rieusset, Alain Lacampagne, Jérémy Fauconnier · 2021 · Frontiers in Cell and Developmental Biology
  3. Skeletal muscle mitochondria in health and disease
    Agnese De Mario, Gaia Gherardi, Rosario Rizzuto, Cristina Mammucari · 2021 · Cell Calcium
  4. Mitochondrial stress responses in Duchenne muscular dystrophy: metabolic dysfunction or adaptive reprogramming?
    Catherine A. Bellissimo, Madison C. Garibotti, Christopher G. R. Perry · 2022 · American Journal of Physiology-Cell Physiology
  5. Disrupted autophagy undermines skeletal muscle adaptation and integrity
    Elliot J. Jokl, Gonzalo Blanco · 2016 · Mammalian Genome
  6. Deficiency of fibroblast growth factor 21 aggravates obesity-induced atrophic responses in skeletal muscle
    Chu-Sook Kim, Yeonsoo Joe, Hye‐Seon Choi, Sung Hoon Back, Jeong Woo Park, Hun‐Taeg Chung, Eun Roh, Min‐Seon Kim, Tae Youl Ha, Rina Yu · 2019 · Journal of Inflammation
  7. Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy
    Tirsa L.E. van Westering, Henrik J. Johansson, Britt Hanson, Anna M. L. Coenen-Stass, Yulia N. Lomonosova, Jun Tanihata, Norio Motohashi, Toshifumi Yokota, Shin’ichi Takeda, Janne Lehtiö et al. · 2020 · Molecular & Cellular Proteomics
  8. The Signaling Network Resulting in Ventilator-induced Diaphragm Dysfunction
    Huibin Tang, Joseph B. Shrager · 2018 · American Journal of Respiratory Cell and Molecular Biology
  9. Activation of autophagy by globular adiponectin is required for muscle differentiation
    Tania Gamberi, Alessandra Modesti, Francesca Magherini, Donna M. D’Souza, Thomas James Hawke, Tania Fiaschi · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  10. Melanocytes—A novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy
    Camilla Pellegrini, Alessandra Zulian, Francesca Gualandi, Elisa Manzati, Luciano Merlini, Maria Elena Michelini, Luisa Benassi, Sandra Marmiroli, Alessandra Ferlini, Patrizia Sabatelli et al. · 2012 · Journal of Cellular Physiology
  11. Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy
    Clàudia Cerveró, Neus Montull, Olga Tarabal, Lídia Piedrafita, Josep Enric Esquerda, Jordi Calderó · 2015 · Neurotherapeutics
  12. Molecular and metabolomic effects of voluntary running wheel activity on skeletal muscle in late middle-aged rats
    Sean M. Garvey, David W. Russ, Mary B. Skelding, Janis E. Dugle, Neilé K. Edens · 2015 · Physiological Reports
  13. Autophagic dysfunction and autophagosome escape in the mdx mus musculus model of Duchenne muscular dystrophy
    Hannah Rose Spaulding, Ellen M. Kelly, John C. Quindry, Joel B. Sheffield, Matthew B. Hudson, Joshua T. Selsby · 2017 · Acta Physiologica
  14. Down-regulation of AMPK signaling pathway rescues hearing loss in TFB1 transgenic mice and delays age-related hearing loss
    Jingjing Zhao, Gen Li, Xuan Zhao, Xin Lin, Yunge Gao, Nuno Raimundo, Geng‐Lin Li, Wei Shang, Hao Wu, Lei Song · 2020 · Aging
  15. Ketogenic essential amino acids replacement diet ameliorated hepatosteatosis with altering autophagy-associated molecules
    Ling Xu, Megumi Kanasaki, Jianhua He, Munehiro Kitada, Kenji Nagao, Hiroko Jinzu, Yasushi Noguchi, Hiroshi Maegawa, Keizo Kanasaki, Daisuke Koya · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  16. Recent advances in mitochondrial turnover during chronic muscle disuse
    Liam D. Tryon, Anna Vainshtein, Jonathan Matthew Memme, Matthew J. Crilly, David Albert Hood · 2014 · Integrative Medicine Research
  17. Nanotherapy for Duchenne muscular dystrophy
    Michael E. Nance, Chady H. Hakim, N. Nora Yang, Dongsheng Duan · 2017 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  18. Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy
    Sajedah M. Hindi, Shuichi Sato, Yongwon Choi, Ashok Kumar · 2013 · Human Molecular Genetics
  19. Mitochondria and Reactive Oxygen Species: The Therapeutic Balance of Powers for Duchenne Muscular Dystrophy
    Silvia Rosanna Casati, Davide Cervia, Paulina Roux-Biejat, Claudia Moscheni, Cristiana Perrotta, Clara De Palma · 2024 · Cells
  20. Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy
    Emma Rybalka, Cara A. Timpani, Christos G. Stathis, Alan Hayes, Matthew B. Cooke · 2015 · Nutrients
  21. Muscle stem cells in Duchenne muscular dystrophy exhibit molecular impairments and altered cell fate trajectories impacting regenerative capacity
    Jules A Granet, Rebecca Robertson, Alessio A Cusmano, Romina L. Filippelli, Tim O Lorenz, Shulei Li, Moein Yaqubi, Jo Anne Stratton, Natasha C. Chang · 2025 · Cell Death and Disease
  22. Combined Strategies for Maintaining Skeletal Muscle Mass and Function in Aging: Myostatin Inactivation and AICAR-Associated Oxidative Metabolism Induction
    Marion Pauly, Béatrice Chabi, François Bertrand Favier, Frankie Vanterpool, Stéfan Matecki, Gilles Fouret, Béatrice Bonafos, Barbara Vernus, Christine Feillet‐Coudray, Charles Coudray et al. · 2014 · The Journals of Gerontology Series A
  23. Mitochondrial-specific autophagy linked to mitochondrial dysfunction following traumatic freeze injury in mice
    Anna S. Nichenko, William M. Southern, Kayvan F. Tehrani, Anita Qualls, Alexandra B. Flemington, Grant H. Mercer, Amelia Yin, Luke J. Mortensen, Hang Yin, Jarrod A. Call · 2019 · American Journal of Physiology-Cell Physiology
  24. Type 2 diabetes-induced overactivation of P300 contributes to skeletal muscle atrophy by inhibiting autophagic flux
    Zhen Fan, Jing Wu, Qiu-nan Chen, Ankang Lyu, Jinliang Chen, Yue Sun, Qiong Lyu, Yuxing Zhao, Ai Guo, Zhiyin Liao et al. · 2020 · Life Sciences
  25. The bidirectional relationship between AMPK pathway activation and myokine secretion in skeletal muscle: How it affects energy metabolism
    Mahdi Ahsan, Léa Garneau, Céline Aguer · 2022 · Frontiers in Physiology
  26. AMPK is mitochondrial medicine for neuromuscular disorders
    Andrew I. Mikhail, Sean Y. Ng, Stephanie R. Mattina, Vladimir Ljubicic · 2023 · Trends in Molecular Medicine
  27. Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy
    Steven J. Foltz, Jun-Na Luan, Jarrod A. Call, Ankitkumar Patel, Kristen B. Peissig, Marisa J. Fortunato, Aaron M. Beedle · 2016 · Skeletal Muscle
  28. Satellite cells fail to contribute to muscle repair but are functional in Pompe disease (glycogenosis type II)
    Lydie Lagalice, Julien Pichon, Eliot Gougeon, Salwa Soussi, Johan Deniaud, Mireille Ledevin, Virginie Maurier, Isabelle Leroux, Sylvie Durand, Carine Ciron et al. · 2018 · Acta Neuropathologica Communications
  29. Dystrophinopathy-associated dysfunction of Krebs cycle metabolism
    Angus Lindsay, Christopher M. Chamberlain, Bruce A. Witthuhn, Dawn A. Lowe, James M. Ervasti · 2018 · Human Molecular Genetics
  30. The physiological response of protease inhibition in dystrophic muscle
    Katrin Hollinger, Joshua Taylor Selsby · 2013 · Acta Physiologica
  31. High‐intensity interval training in the form of isometric contraction improves fatigue resistance in dystrophin‐deficient muscle
    Nao Yamauchi, Katsuyuki Tamai, Iori Kimura, Azuma Naito, Nao Tokuda, Yuki Ashida, Norio Motohashi, Yoshitsugu Aoki, Takashi Yamada · 2023 · The Journal of Physiology
  32. Advances in Dystrophinopathy Diagnosis and Therapy
    Fawzy Ali Saad, Gabriele Siciliano, Corrado Italo Angelini · 2023 · Biomolecules
  33. Skeletal Muscle Mitochondria Dysfunction in Genetic Neuromuscular Disorders with Cardiac Phenotype
    Elena V. Ignatieva, Natalia Smolina, Anna Aleksandrovna Kostareva, Renata I. Dmitrieva · 2021 · International Journal of Molecular Sciences
  34. A Brief Review of Duchenne Muscular Dystrophy Treatment Options, with an Emphasis on Two Novel Strategies
    Ahlke Heydemann, Maria Siemionow · 2023 · Biomedicines
  35. Dynamic transcriptomic analysis in hircine longissimus dorsi muscle from fetal to neonatal development stages
    Siyuan Zhan, Wei Han Zhao, Tianzeng Song, Yao Dong, Jiazhong Guo, Jiaxue Cao, Tao Zhong, Linjie Wang, Li Li, Hongping Zhang · 2017 · Functional & Integrative Genomics
  36. PGC‐1α overexpression increases transcription factor EB nuclear localization and lysosome abundance in dystrophin‐deficient skeletal muscle
    Spaulding, Hannah R., Ludwig, Amanda K., Hollinger, Katrin, Hudson, Matthew B., Selsby, Joshua T. · 2020 · Physiological Reports
  37. Supplementation with a selective amino acid formula ameliorates muscular dystrophy in mdx mice
    Stefania Banfi, Giuseppe D’Antona, Chiara Ruocco, Mirella Meregalli, M. Belicchi, Pamela Bella, Silvia Erratico, Elisa Donato, Fabio M V Rossi, Francesco Bifari et al. · 2018 · Scientific Reports
  38. Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
    Katarzyna Kaziród, Małgorzata Myszka, Józef Dulak, Agnieszka Łoboda · 2022 · Cellular and Molecular Life Sciences
  39. Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response
    Shivam Gandhi, Hugh Lee Sweeney, Cora C. Hart, Renzhi Han, Christopher G. R. Perry · 2024 · Cells
  40. Sarcolipin deletion exacerbates soleus muscle atrophy and weakness in phospholamban overexpressing mice
    Val Andrew Fajardo, Daniel Gamu, Andrew S Mitchell, Darin Bloemberg, Éric Bombardier, Paige J. Chambers, Catherine A. Bellissimo, Joe Quadrilatero, Allan Russell Tupling · 2017 · PLoS ONE
  41. 201st ENMC International Workshop: Autophagy in muscular dystrophies – Translational approach, 1–3 November 2013, Bussum, The Netherlands
    Luciano Merlini, Ichizo Nishino · 2014 · Neuromuscular Disorders
  42. Mitochondrial Dysfunction in Duchenne Muscular Dystrophy
    Marie L. Kelly-Worden, Emily Thomas · 2014 · Open Journal of Endocrine and Metabolic Diseases
  43. Acute Heat Exposure Alters Autophagy Signaling in C2C12 Myotubes
    Corey M. Summers, Rudy J. Valentine · 2020 · Frontiers in Physiology
  44. Dysregulated Autophagy and Mitophagy in a Mouse Model of Duchenne Muscular Dystrophy Remain Unchanged Following Heme Oxygenase-1 Knockout
    Olga Mucha, Katarzyna Kaziród, Paulina Podkalicka, Kinga Rusin, Józef Dulak, Agnieszka Łoboda · 2021 · International Journal of Molecular Sciences
  45. Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner
    Naomi S Misquitta, Aymeric Ravel‐Chapuis, Bernard Jean Jasmin · 2022 · Human Molecular Genetics
  46. Ventilator-induced diaphragmatic dysfunction: pathophysiology, monitoring and advances in potential treatment and prevention
    Wei Dong Fu, Lili Guan, Qi Liu, Zhefan Xie, Junting You, Rongchang Chen · 2025 · European Respiratory Review
  47. AMPK activation restores ischemic post-conditioning cardioprotection in STZ-induced type 1 diabetic rats: Role of autophagy
    Bin Zhou, Yan Leng, Shaoqing Lei, Zhongyuan Xia · 2017 · Molecular Medicine Reports
  48. Indices of Defective Autophagy in Whole Muscle and Lysosome Enriched Fractions From Aged D2-mdx Mice
    Swathy Krishna, Hannah Rose Spaulding, Tiffany S. Quindry, Matthew B. Hudson, John C. Quindry, Joshua Taylor Selsby · 2021 · Frontiers in Physiology
  49. Acute, next‐generation AMPK activation initiates a disease‐resistant gene expression program in dystrophic skeletal muscle
    Sean Y. Ng, Andrew I. Mikhail, Stephanie R. Mattina, Alexander Manta, Ian J. Diffey, Vladimir Ljubicic · 2023 · The FASEB Journal
  50. Insight into the Role of Gut Microbiota in Duchenne Muscular Dystrophy
    Maxence Jollet, Mahendra Mariadassou, Olivier Rué, Laurence Pessemesse, Vincent Ollendorff, Sofiane Ramdani, Barbara Vernus, Anne Bonnieu, Christelle Bertrand‐Gaday, Bénédicte Goustard et al. · 2023 · American Journal Of Pathology
  51. Duchenne muscular dystrophy drug discovery – the application of utrophin promoter activation screening
    Catherine Moorwood, Tejvir S. Khurana · 2013 · Expert Opinion on Drug Discovery
  52. Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy
    Rebecca E. Schmitt, Douglas Y. Smith, Dong Seong Cho, Lindsey A. Kirkeby, Zachary T. Resch, Teerin Liewluck, Zhiyv Niu, Margherita Milone, Jason D. Doles · 2022 · npj Regenerative Medicine
  53. Carm1 and the Epigenetic Control of Stem Cell Function
    John Saber, Michael A. Rudnicki · 2022 · Stem Cells Translational Medicine
  54. Mitochondrial quality control in liver fibrosis: Epigenetic hallmarks and therapeutic strategies
    Lin Jia, Yang Yang, Feng Sun, Hui Tao, Chao Lu, Jingjing Yang · 2024 · Cellular Signalling
  55. Opposing effects of intracellular versus extracellular adenine nucleotides on autophagy: implications for β-cell function
    Tal Israeli, Yael Riahi, Ann Saada, Devorah Yefet, Erol Cerasi, Boaz Tirosh, Gil Leibowitz · 2018 · Journal of Cell Science
  56. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.mdx mouse model of Duchenne muscular dystrophy
    Catherine A. Bellissimo, Shivam Gandhi, Laura N. Castellani, Mayoorey Murugathasan, Luca J. Delfinis, Arshdeep K. Thuhan, Madison C. Garibotti, Yeji Seo, Irena A. Rebalka, Henry H. Hsu et al. · 2023 · American Journal of Physiology-Cell Physiology
  57. Chinese leek-derived extracellular vesicles ameliorate sarcopenia by regulating mitochondrial biogenesis and autophagy via AMPK and maintaining myosin homeostasis
    Weihui Qi, Libin Yang, Yanli Pan, Ke Lv, Lan Zhao, Yujun Zhang, Guoyin Kai, Yue-Li Sun, Hao Pan, Dong Wang · 2025 · Journal of Nanobiotechnology
  58. Ventilator‐induced diaphragmatic dysfunction in MDX mice
    Feng Liang, Tong Li, Ilan Azuelos, Christian Giordano, Han Liang, Sabah N. A. Hussain, Stéfan Matecki, Basil J. Petrof · 2017 · Muscle & Nerve
  59. Modulation of PGC-1α activity as a treatment for metabolic and muscle-related diseases
    Kristoffer Svensson, Christoph Handschin · 2014 · Drug Discovery Today
  60. IGF-1 potentiates sensory innervation signalling by modulating the mitochondrial fission/fusion balance
    Yuan Ding, Jianmin Li, Zhen Liu, Huaxiang Liu, Hao Li, Zhenzhong Li · 2017 · Scientific Reports
  61. Molecular pathways involved in the control of contractile and metabolic properties of skeletal muscle fibers as potential therapeutic targets for Duchenne muscular dystrophy
    Agnese Bonato, Giada Raparelli, Maurizia Caruso · 2024 · Frontiers in Physiology
  62. Increased AMP-activated protein kinase in skeletal muscles of Murphy Roth Large mice and its potential role in altered metabolism
    Tirsit K. Berhanu, Jenan Holley-Cuthrell, Nathan W. Roberts, Aaron J. Mull, Ahlke Heydemann · 2014 · Physiological Reports
  63. Influence of chrysin on D‐galactose induced‐aging in mice: Up regulation of AMP kinase/liver kinase B1/peroxisome proliferator‐activated receptor‐γ coactivator 1‐α signaling pathway
    Abeer Salama, Rania Elgohary · 2023 · Fundamental and Clinical Pharmacology
  64. Nanoparticle delivery of AMPK activator 991 prevents its toxicity and improves muscle homeostasis in Duchenne muscular dystrophy
    Ilaria Andreana, Ananga Ghosh, Mathieu Repellin, Anita E. M. Kneppers, Sabrina Ben Larbi, Federica Tifni, Aurélie Fessard, Marion J. Martin, Jacqueline Sidi‐Boumedine, David Kryza et al. · 2025 · Molecular Therapy — Methods & Clinical Development
  65. Impaired autophagy correlates with golden retriever muscular dystrophy phenotype
    William B. Stoughton, Jianrong Li, Cindy Balog‐Alvarez, Joe N. Kornegay · 2018 · Muscle & Nerve
  66. Leucyl-tRNA Synthetase Contributes to Muscle Weakness through Mammalian Target of Rapamycin Complex 1 Activation and Autophagy Suppression in a Mouse Model of Duchenne Muscular Dystrophy
    Jae‐Sung You, Kate Karaman, Adriana Reyes‐Ordoñez, Soohyun Lee, Yongdeok Kim, Rashid Bashir, Jie Chen · 2024 · American Journal Of Pathology
  67. Effect of pyridostigmine on in vivo and in vitro respiratory muscle of mdx mice
    Gabriela de Cássia Sousa Amâncio, Andrea Grabe‐Guimarães, Haikel Dridi, Johan Moreau, Neila Márcia Silva-Barcellos, Alain Lacampagne, Stéfan Matecki, Olivier Cazorla · 2017 · Respiratory Physiology & Neurobiology
  68. Transplantation of Muscle Stem Cell Mitochondria Rejuvenates the Bioenergetic Function of Dystrophic Muscle
    Mahir Mohiuddin, Jeongmoon J. Choi, Nan Hee Lee, Hyeonsoo Jeong, Shannon E. Anderson, Woojin M. Han, Berna Aliya, Tsvetomira Z. Peykova, Sumit Verma, Andrés J. Garcı́a et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  69. A fat- and sucrose-enriched diet causes metabolic alterations in mdx mice
    Swathy Krishna, Kenneth G. Echevarria, Carter H. Reed, Hyeyoon Eo, Michelle Wintzinger, Mattia Quattrocelli, Rudy J. Valentine, Joshua Taylor Selsby · 2023 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  70. The Structural and Functional Characteristics of the Motor End Plates of Dysferlin-Deficient Mice
    Кравцова Виолетта Васильевна, Н. А. Тимонина, G. F. Zakir’yanova, A. V. Sokolova, Vyacheslav M. Mikhailov, Andrey Lvovich Zefirov, Igor I. Krivoi · 2018 · Neurochemical Journal
  71. Mitochondrial dysfunction in skeletal muscle of fukutin‐deficient mice is resistant to exercise‐ and 5‐aminoimidazole‐4‐carboxamide ribonucleotide‐induced rescue
    William M. Southern, Anna S. Nichenko, Anita Qualls, Kensey Portman, Ariel Gidon, Aaron M. Beedle, Jarrod A. Call · 2020 · Experimental Physiology
  72. Curcumin Administration Improves Force of mdx Dystrophic Diaphragm by Acting on Fiber-Type Composition, Myosin Nitrotyrosination and SERCA1 Protein Levels
    Luisa Gorza, Elena Germinario, Maurizio Vitadello, Irene Guerra, Federica De Majo, Francesca Gasparella, Paolo Caliceti, Libero Vitiello, Daniela Danieli‐Betto · 2023 · Antioxidants
  73. Running improves muscle mass by activating autophagic flux and inhibiting ubiquitination degradation in mdx mice
    Shanyao Zhou, Si Lei, Yanling She, Huacai Shi, Yang Li, Xin Zhou, Rui Chen · 2024 · Gene
  74. Identification of differentially expressed genes at different post-natal development stages of longissimus dorsi muscle in Tianzhu white yak
    Bingang Shi, Xuehong Shi, Zhi Zuo, Shijie Zhao, Zhidong Zhao, Jiqing Wang, Huitong Zhou, Yuzhu Luo, Jiang Hu, Jon G. H. Hickford · 2022 · Gene
  75. Is the fundamental pathology in Duchenne's muscular dystrophy caused by a failure of glycogenolysis–glycolysis in costameres?
    Vishakha Nesari, Suresh Balakrishnan, Upendra Nongthomba · 2023 · Journal of Genetics
  76. Integrin and Adhesion Regulation of Autophagy and Mitophagy
    Eric A., K. Cindy · 2013 · InTech eBooks
  77. Interplay Between Metabolic Sensors and Immune Cell Signaling
    Prashant Singh Chauhan, Arup Sarkar, Bhaskar Saha · 2018 · Experientia supplementum
  78. Misregulation of the Ubiquitin–Proteasome System and Autophagy in Muscular Dystrophies Associated with the Dystrophin–Glycoprotein Complex
    Manuela Bozzi, Francesca Sciandra, Maria Giulia Bigotti, Andrea Brancaccio · 2025 · Cells
  79. Chronic 5-Aminoimidazole-4-Carboxamide-1-β-d-Ribofuranoside Treatment Induces Phenotypic Changes in Skeletal Muscle, but Does Not Improve Disease Outcomes in the R6/2 Mouse Model of Huntington’s Disease
    Marie‐France Paré, Bernard Jean Jasmin · 2017 · Frontiers in Neurology
  80. Mitochondrial cardiomyopathy and emerging therapeutics
    Jinjuan Yang, Xiaoxian Zhang, Meng Kou, Boon Xuan Lian, Zhixin Chiang, Jace Chen, Xiaoya Zhou, Ziyue Li, Jinqiu Zhang, Xiao Su et al. · 2023 · Translational Medicine of Aging
  81. Myopathies with Myofibrillar Pathology
    Pitcha Chompoopong, Margherita Milone · 2023 · Current clinical neurology
  82. Molecular basis of muscle hypertrophy and atrophy: Potential therapy for muscular dystrophy
    Naoki Ito, Yuko Miyagoe‐Suzuki, Shin’ichi Takeda · 2013 · The Journal of Physical Fitness and Sports Medicine
  83. A Review of Mathematical Models for Muscular Dystrophy: A Systems Biology Approach
    Matthew T Houston, A. Cameron, Juan B. Gutiérrez · 2016 · PLoS Currents
  84. Targeted regulation of TAK1 counteracts dystrophinopathy in a DMD mouse model
    Anirban Roy, Tatiana Emy Koike, Aniket S. Joshi, Meiricris Tomaz da Silva, Kavya Mathukumalli, Mingfu Wu, Ashok Kumar · 2023 · JCI Insight
  85. LEDT and Idebenone treatment modulate autophagy and improve regenerative capacity in the dystrophic muscle through an AMPK-pathway
    Heloina Nathalliê Mariano da Silva, Evelyn Mendes Fernandes, Valéria Andrade Pereira, Daniela Sayuri Mizobuti, Caroline Covatti, Guilherme Luiz da Rocha, Elaine Minatel · 2024 · PLoS ONE
  86. Direct AMPK Activation Confers Mutation‐Independent Therapeutic Benefit in Duchenne Muscular Dystrophy
    Sean Y. Ng, Andrew I. Mikhail, Stephanie R. Mattina, Magda A. Lesinski, Irena A. Rebalka, Sophie I. Hamstra, Donald Xhuti, Val Andrew Fajardo, Mark Andrew Tarnopolsky, Joshua P. Nederveen et al. · 2026 · Journal of Cachexia Sarcopenia and Muscle
  87. The role of 5′-adenosine monophosphate-activated protein kinase (AMPK) in skeletal muscle atrophy
    Kai Dang, Hafiz Muhammad Umer Farooq, YUAN GAO, Xiaoni Deng, Airong Qian · 2022 · Biocell
  88. Drug Discovery Approaches for Rare Neuromuscular Diseases
    Graham M. Wynne, Angela J. Russell · 2014 · Royal Society of Chemistry eBooks
  89. L-NAME improves the morphology and necrosis of skeletal muscle by activating PINK1-PARKIN mediated mitophagy in mdx mice
    Junxia Li, Wenjuan Wu, Guang Ji, Hui Dong, Hongran Wu, Xueqin Song · 2025 · Brain and Development
  90. Mitochondria in muscle stem cell biology: gatekeepers of fate, function, and regeneration
    Mireille Khacho, Yan Burelle · 2026 · American Journal of Physiology-Cell Physiology
  91. In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
    Francesco Castagnetti, Elisabetta Fiacco, Carol Imbriano, Lucia Latella · 2017 · Journal of Visualized Experiments
  92. The adiponectin analogue ALY688-SR attenuates diaphragm fibrosis, atrophy and mitochondrial stress in a mouse model of Duchenne muscular dystrophy
    Catherine A. Bellissimo, Shivam Gandhi, Laura N. Castellani, Mayoorey Murugathasan, Luca J. Delfinis, Arshdeep K. Thuhan, Madison C. Garibotti, Yeji Seo, Irena A. Rebalka, Gary Sweeney et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Exploring new therapeutics for Duchenne muscular dystrophy and related cardiomyopathy
    Bin Li, Weiyao Xiong, Andrew Chia Hao Chang, Alex Chia Yu Chang · 2025 · Rare Disease and Orphan Drugs Journal
  94. Branched Chain Amino Acids in Inherited Muscle Disease: The Case of Duchenne Muscular Dystrophy
    Jamshid Davoodi, Susan M. Hutson, Robert W. Grange · 2014 · Springer eBooks
  95. Skeletal muscle
    Greg Robert Markby, Kei Sakamoto · 2021 · Elsevier eBooks
  96. The MRL Mitochondrial Genome Decreases Murine Muscular Dystrophy Severity
    Jenan Holley-Cuthrell, Aqsa Iqbal, Ahlke Heydemann · 2023 · Muscles
  97. RevAMP(K)ing Mitochondria for Sarcoglycanopathy Therapeutics
    David W. Hammers · 2019 · Circulation Heart Failure
  98. Signaling mechanisms in regenerative myogenesis.
    Sajedah M. Hindi · 2014
  99. Melanocytes: a new potential tool to study and monitoring Duchenne muscular dystrophy
    Camilla Pellegrini · 2013 · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna)
  100. Resveratrol as a Novel Therapeutic Agent for Treating Duchenne Muscular Dystrophy
    Burt, Matthew · 2013 · uO Research (University of Ottawa)